Exelixis (EXEL)

65 patents

Page 4 of 4
C-Met modulator pharmaceutical compositions
3 Feb 20
Jo Ann Wilson, Khalid Shah
Filed: 2 Jul 18
Mek Inhibitors and Methods of Their Use
29 Jan 20
Disclosed are compounds of Formula (I) and pharmaceutically acceptable salts and solvates thereof.
Naing Aay, Neel Kumar Anand, Charles M. Blazey, Owen Joseph Bowles, Joerg Bussenlus, Simona Costanzo, Jeffry Kimo Curtis, Steven Charles DeFina, Larisa Dubenko, Anagha Abhijit Joshi, Abigall R. Kennedy, Angle Inyoung Kim, Elena S. Koltun, Jean-Claire Limun Manalo, Csaba J. Peto, Kenneth D. Rice, Tsze H. Tsang
Filed: 8 Oct 19
Processes for preparing quinoline compounds and pharmaceutical compositions containing such compounds
27 Jan 20
Jo Ann Wilson, Khalid Shah
Filed: 3 Oct 18
Crystalline solid forms of N-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-N′-(4-fluorophenyl) cyclopropane-1,1-dicarboxamide, processes for making, and methods of use
9 Dec 19
The invention relates to novel crystalline solid forms of the chemical compound N-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-N′-(4-fluorophenyl) cyclopropane-1,1-dicarboxamide (Compound 1), and solvates thereof, including hydrates, that are useful for the treatment of cancer.
Dana T. Aftab, Nathan Guz, Stephen Lau, Noel Hamill, Tracy Walker, Jana Galbraith, Simon Yau, Khalid Shah
Filed: 15 Feb 15
Combinations of Cabozantinib and Atezolizumab to Treat Cancer
20 Nov 19
This invention relates to the combination of cabozantinib and atezolizumab to treat locally advanced or metastatic solid tumors, particularly advanced urothelial cancer or renal cell carcinoma.
Gisela Schwab, Christian Scheffold, Colin Hessel
Filed: 18 Jan 18
Patents are sorted by USPTO publication date, most recent first